[HTML][HTML] A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

…, HW Tsoi, SKF Lo, KH Chan, VKM Poon, WM Chan… - The lancet, 2020 - thelancet.com
Background An ongoing outbreak of pneumonia associated with a novel coronavirus was
reported in Wuhan city, Hubei province, China. Affected patients were geographically linked …

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort …

…, CYC Choi, LL Chen, WM Chan, KH Chan… - The Lancet infectious …, 2020 - thelancet.com
Background Coronavirus disease 2019 (COVID-19) causes severe community and nosocomial
outbreaks. Comprehensive data for serial respiratory viral load and serum antibody …

[HTML][HTML] Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label …

…, TC Wu, JWM Chan, WW Yan, WM Chan, JFW Chan… - The Lancet, 2020 - thelancet.com
Background Effective antiviral therapy is important for tackling the coronavirus disease 2019
(COVID-19) pandemic. We assessed the efficacy and safety of combined interferon beta-1b, …

[PDF][PDF] COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing

…, IF Hung, JD Ip, AW Chu, WM Chan… - Clin …, 2020 - dubito.s3.eu-central-1.amazonaws …
… Authors: Kelvin Kai-Wang To 1,2* , Ivan Fan-Ngai Hung 3 *,Jonathan Daniel Ip 1 , Allen
WingHo Chu 1 , Wan-Mui Chan 1 , Anthony Raymond Tam 3 , Carol Ho-Yan Fong 1 , Shuofeng …

[HTML][HTML] Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations …

H Chu, JFW Chan, TTT Yuen, H Shuai, S Yuan… - The Lancet …, 2020 - thelancet.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported
from China in January, 2020. SARS-CoV-2 is efficiently transmitted from person to person …

Neutralization of severe acute respiratory syndrome coronavirus 2 omicron variant by sera from BNT162b2 or CoronaVac vaccine recipients

…, AWH Chu, WM Chan, JD Ip, BPC Chan… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron
variant, designated as a variant of concern by the World Health Organization, carries …

Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a golden Syrian hamster model: implications for disease …

…, CCS Chan, ACY Lee, WM Chan… - Clinical infectious …, 2020 - academic.oup.com
Background A physiological small-animal model that resembles COVID-19 with low
mortality is lacking. Methods Molecular docking on the binding between angiotensin-converting …

SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells

…, JD Ip, WM Chan, AWH Chu, KH Chan… - Emerging microbes & …, 2022 - Taylor & Francis
The novel SARS-CoV-2 Omicron variant (B.1.1.529), first found in early November 2021, has
sparked considerable global concern and it has >50 mutations, many of which are known …

Coronavirus disease 2019 (COVID-19) re-infection by a phylogenetically distinct severe acute respiratory syndrome coronavirus 2 strain confirmed by whole genome …

…, IFN Hung, JD Ip, AWH Chu, WM Chan… - Clinical Infectious …, 2021 - academic.oup.com
Background Waning immunity occurs in patients who have recovered from Coronavirus
Disease 2019 (COVID-19). However, it remains unclear whether true re-infection occurs. …

Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters

…, AJ Zhang, G Lu, CP Ong, VK Man Poon, CCS Chan… - Science, 2022 - science.org
The in vivo pathogenicity, transmissibility, and fitness of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant are not well understood. We …